Availability and affordability of anticancer medicines in Iran based on WHO/HAI standard survey methods.
Mehdi VarmaghaniSepideh ElyasiMohammad M MojahedianVahid GhavamiBehnam BorhaniJavad Javan-NoughabiShirin SarafrazPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
Unaffordability of cancer medicines can lead to treatment abandonment and increase inequality in access to healthcare services. Therefore, this requires immediate attention of policy makers to be planned in order to ensure to reducing the costs of medicines for patients and increasing patient access to anticancer medicines.
Keyphrases
- healthcare
- end stage renal disease
- ejection fraction
- newly diagnosed
- public health
- mental health
- chronic kidney disease
- primary care
- prognostic factors
- papillary thyroid
- peritoneal dialysis
- case report
- cross sectional
- young adults
- health insurance
- childhood cancer
- patient reported
- affordable care act
- combination therapy